<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font28 { font-size : 28; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">treatment </span>
   <span class="font28">care </span>
   <span class="font28">integrated </span>
   <span class="font23">HIV </span>
   <span class="font23">intervention </span>
   <span class="font23">group </span>
   <span class="font22">studies </span>
   <span class="font21">OAT </span>
   <span class="font20">use </span>
   <span class="font20">control </span>
   <span class="font18">people </span>
   <span class="font18">participants </span>
   <span class="font16">[]. </span>
   <span class="font16">substance </span>
   <span class="font16">HCV </span>
   <span class="font16">effect </span>
   <span class="font15">included </span>
   <span class="font15">patients </span>
   <span class="font15">models </span>
   <span class="font15">study </span>
   <span class="font15">DOT </span>
   <span class="font15">SUD </span>
   <span class="font15">opioid </span>
   <span class="font14">compared </span>
   <span class="font14">health </span>
   <span class="font14">significant </span>
   <span class="font14">infectious </span>
   <span class="font14">randomized </span>
   <span class="font14">versus </span>
   <span class="font14">review </span>
   <span class="font14">systematic </span>
   <span class="font13">adherence </span>
   <span class="font13">completion </span>
   <span class="font13">therapy </span>
   <span class="font13">{border-style </span>
   <span class="font13">Health </span>
   <span class="font13">hepatitis </span>
   <span class="font13">SVR </span>
   <span class="font13">px;} </span>
   <span class="font13">receives </span>
   <span class="font13">suppression </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">&amp;lt; </span>
   <span class="font13">characteristics </span>
   <span class="font13">drug </span>
   <span class="font13">mental </span>
   <span class="font13">outcomes </span>
   <span class="font13">severe </span>
   <span class="font12">.), </span>
   <span class="font12">diseases </span>
   <span class="font12">evaluated </span>
   <span class="font12">group, </span>
   <span class="font12">high </span>
   <span class="font12">interventions </span>
   <span class="font12">psychosocial </span>
   <span class="font12">results </span>
   <span class="font12">clinic </span>
   <span class="font12">cohort </span>
   <span class="font12">different </span>
   <span class="font12">disorder </span>
   <span class="font12">received </span>
   <span class="font12">response </span>
   <span class="font12">treatment. </span>
   <span class="font12">used </span>
   <span class="font12">viral </span>
   <span class="font12">RCT </span>
   <span class="font12">World </span>
   <span class="font12">differences </span>
   <span class="font12">psychological </span>
   <span class="font12">search </span>
   <span class="font12">virus </span>
   <span class="font12">controlled </span>
   <span class="font12">relevant </span>
   <span class="font12">standard </span>
   <span class="font12">treatment, </span>
   <span class="font12">ART </span>
   <span class="font12">Hepatitis </span>
   <span class="font12">agonist </span>
   <span class="font12">analysis </span>
   <span class="font12">improve </span>
   <span class="font12">infected </span>
   <span class="font12">medical </span>
   <span class="font12">primary </span>
   <span class="font12">psychiatric </span>
   <span class="font12">rate </span>
   <span class="font12">risk </span>
   <span class="font12">services </span>
   <span class="font12">However, </span>
   <span class="font12">Integrated </span>
   <span class="font12">achieved </span>
   <span class="font12">effects </span>
   <span class="font12">groups </span>
   <span class="font12">loss-to-follow-up </span>
   <span class="font12">model </span>
   <span class="font12">respectively. </span>
   <span class="font12">social </span>
   <span class="font12">tuberculosis </span>
   <span class="font11">Participants </span>
   <span class="font11">article </span>
   <span class="font11">directly </span>
   <span class="font11">drugs </span>
   <span class="font11">including </span>
   <span class="font11">outpatient </span>
   <span class="font11">recruited </span>
   <span class="font11">showed </span>
   <span class="font11">studies, </span>
   <span class="font11">virological </span>
   <span class="font11">Basic </span>
   <span class="font11">HIV, </span>
   <span class="font11">Organization; </span>
   <span class="font11">RNA </span>
   <span class="font11">Substance </span>
   <span class="font11">[], </span>
   <span class="font11">antiretroviral </span>
   <span class="font11">cell </span>
   <span class="font11">chronic </span>
   <span class="font11">clinic. </span>
   <span class="font11">collaborative </span>
   <span class="font11">completion. </span>
   <span class="font11">defined </span>
   <span class="font11">did </span>
   <span class="font11">given </span>
   <span class="font11">group. </span>
   <span class="font11">groups. </span>
   <span class="font11">increase </span>
   <span class="font11">multidisciplinary </span>
   <span class="font11">observed </span>
   <span class="font11">outcome </span>
   <span class="font11">significantly </span>
   <span class="font11">strategy </span>
   <span class="font11">uncertain </span>
   <span class="font11">age </span>
   <span class="font11">assessed </span>
   <span class="font11">definition </span>
   <span class="font11">dependence </span>
   <span class="font11">disorders </span>
   <span class="font11">file </span>
   <span class="font11">group: </span>
   <span class="font11">hospitalized </span>
   <span class="font11">low </span>
   <span class="font11">months </span>
   <span class="font11">px; </span>
   <span class="font11">transmitted </span>
   <span class="font11">week </span>
   <span class="font11">{font-family </span>
   <span class="font11">(%) </span>
   <span class="font11">OAT. </span>
   <span class="font11">RCT. </span>
   <span class="font11">antiviral </span>
   <span class="font11">baseline </span>
   <span class="font11">clinical </span>
   <span class="font11">delivered </span>
   <span class="font11">evaluate </span>
   <span class="font11">follow </span>
   <span class="font11">font-size </span>
   <span class="font11">groups, </span>
   <span class="font11">identified </span>
   <span class="font11">immunodeficiency </span>
   <span class="font11">limited </span>
   <span class="font11">medication </span>
   <span class="font11">references </span>
   <span class="font11">reviews </span>
   <span class="font11">suppression, </span>
   <span class="font11">team </span>
   <span class="font11">terms </span>
   <span class="font11">trial </span>
   <span class="font11">years </span>
   <span class="font11">.). </span>
   <span class="font11">CG: </span>
   <span class="font11">CI, </span>
   <span class="font11">Cohort </span>
   <span class="font11">HBV, </span>
   <span class="font11">In. </span>
   <span class="font11">PWID </span>
   <span class="font11">RCTs </span>
   <span class="font11">SUD. </span>
   <span class="font11">Treatment </span>
   <span class="font11">University </span>
   <span class="font11">baseline, </span>
   <span class="font11">care, </span>
   <span class="font11">coordinated </span>
   <span class="font11">data </span>
   <span class="font11">disorder, </span>
   <span class="font11">double; </span>
   <span class="font11">efficacy </span>
   <span class="font11">evidence </span>
   <span class="font11">global </span>
   <span class="font11">inclusion </span>
   <span class="font11">inject </span>
   <span class="font11">main </span>
   <span class="font11">marginalized </span>
   <span class="font11">methadone </span>
   <span class="font11">models. </span>
   <span class="font11">post-hoc </span>
   <span class="font11">quality </span>
   <span class="font11">quantitative </span>
   <span class="font11">receive </span>
   <span class="font11">receiving </span>
   <span class="font11">reduce </span>
   <span class="font11">reported </span>
   <span class="font11">results. </span>
   <span class="font11">review, </span>
   <span class="font11">review. </span>
   <span class="font11">users </span>
   <span class="font10">(Additional </span>
   <span class="font10">(PDF </span>
   <span class="font10">(n = ) </span>
   <span class="font10">Additionally, </span>
   <span class="font10">CONSORT </span>
   <span class="font10">DAAs </span>
   <span class="font10">Drug </span>
   <span class="font10">HBV </span>
   <span class="font10">Human </span>
   <span class="font10">July </span>
   <span class="font10">LINKAdditional </span>
   <span class="font10">Reporting </span>
   <span class="font10">SUD, </span>
   <span class="font10">Systematic </span>
   <span class="font10">TB: </span>
   <span class="font10">active </span>
   <span class="font10">analysis, </span>
   <span class="font10">approaches </span>
   <span class="font10">assessment </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">criteria </span>
   <span class="font10">design, </span>
   <span class="font10">disease </span>
   <span class="font10">excluded. </span>
   <span class="font10">expect </span>
   <span class="font10">identify </span>
   <span class="font10">impact </span>
   <span class="font10">individuals </span>
   <span class="font10">injection </span>
   <span class="font10">isoniazid </span>
   <span class="font10">kb) </span>
   <span class="font10">lack </span>
   <span class="font10">level </span>
   <span class="font10">literature </span>
   <span class="font10">measure </span>
   <span class="font10">medications </span>
   <span class="font10">methodological </span>
   <span class="font10">new </span>
   <span class="font10">program </span>
   <span class="font10">proportion </span>
   <span class="font10">recruited, </span>
   <span class="font10">regular </span>
   <span class="font10">report </span>
   <span class="font10">self-reported </span>
   <span class="font10">solid; </span>
   <span class="font10">treatments </span>
   <span class="font10">trials </span>
   <span class="font10">virus, </span>
   <span class="font10">weekly </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">(HIV </span>
   <span class="font10">(OATTB: </span>
   <span class="font10">(the </span>
   <span class="font10">AIDS </span>
   <span class="font10">Addiction </span>
   <span class="font10">Baseline </span>
   <span class="font10">Cochrane </span>
   <span class="font10">Embase </span>
   <span class="font10">Haukeland </span>
   <span class="font10">IG: </span>
   <span class="font10">Interventions </span>
   <span class="font10">J.M. </span>
   <span class="font10">Methadone </span>
   <span class="font10">Mycobacterium </span>
   <span class="font10">Randomized </span>
   <span class="font10">Research </span>
   <span class="font10">Standard </span>
   <span class="font10">TB. </span>
   <span class="font10">[–]. </span>
   <span class="font10">additional </span>
   <span class="font10">alcohol </span>
   <span class="font10">antivirals </span>
   <span class="font10">assessing </span>
   <span class="font10">basic </span>
   <span class="font10">better </span>
   <span class="font10">bold </span>
   <span class="font10">care. </span>
   <span class="font10">conducted </span>
   <span class="font10">count </span>
   <span class="font10">courier; </span>
   <span class="font10">description </span>
   <span class="font10">doses </span>
   <span class="font10">em; </span>
   <span class="font10">equal </span>
   <span class="font10">equal, </span>
   <span class="font10">followed </span>
   <span class="font10">fulfilled </span>
   <span class="font10">guidelines </span>
   <span class="font10">high-quality </span>
   <span class="font10">included. </span>
   <span class="font10">individual </span>
   <span class="font10">infection </span>
   <span class="font10">injecting </span>
   <span class="font10">intercourse </span>
   <span class="font10">lifetime </span>
   <span class="font10">meetings </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">modified </span>
   <span class="font10">observatory </span>
   <span class="font10">participants, </span>
   <span class="font10">population </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">p &amp;lt; .). </span>
   <span class="font10">p = .). </span>
   <span class="font10">reach </span>
   <span class="font10">referred </span>
   <span class="font10">sample </span>
   <span class="font10">score </span>
   <span class="font10">search, </span>
   <span class="font10">selection </span>
   <span class="font10">shown </span>
   <span class="font10">similar </span>
   <span class="font10">small </span>
   <span class="font10">strategies </span>
   <span class="font10">studies. </span>
   <span class="font10">study, </span>
   <span class="font10">study. </span>
   <span class="font10">therapy, </span>
   <span class="font10">those, </span>
   <span class="font10">unclear </span>
   <span class="font10">undergoing </span>
   <span class="font10">underpowered </span>
  </p>
 </body>
</html>
